The Human Upgrade: Biohacking for Longevity & Performance Bonus: 'Gene Therapy' featuring Liz Parrish
Apr 23, 2021
Liz Parrish, the Founder and CEO of BioViva, shares her groundbreaking insights into gene therapy and regenerative medicine. She discusses innovative therapies targeting aging, including telomerase inducers and their roles in enhancing mitochondrial function. Liz's personal journey inspired her to advocate for accessible health innovations. They explore the potential of biohacking through quantum science and exciting prospects for enhancing human longevity. Additionally, she introduces the idea of a collective approach to gene therapies, fostering hope for future advancements in health.
AI Snips
Chapters
Books
Transcript
Episode notes
Liz Parrish's Motivation
- Liz Parrish volunteered for stem cell advocacy and learned about regenerative medicine.
- Her son's type 1 diabetes diagnosis in 2013 fueled her pursuit of bringing these technologies to humans.
Targeting Biological Aging
- Liz Parrish realized that treating biological aging addresses the largest unmet medical need.
- This approach can expedite cures for various diseases, including childhood illnesses.
Liz Parrish's Gene Therapies
- Liz Parrish underwent two gene therapies: telomerase induction and follistatin.
- These were delivered using adeno-associated virus (AAV), a safe viral vector.
